Evidence map›Paper›PMID 32251733›Full record

ReviewMethods (San Diego, Calif.)2020

Viral RNA structure analysis using DMS-MaPseq.

Phillip Tomezsko, Harish Swaminathan, Silvi Rouskin

Open access · greenAbstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Ribosome-induced mRNA pseudoknot interactions visualized by DMS MaP-Seq.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Structure of pre-miR-31 reveals an active role in Dicer-TRBP complex processing.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Phillip TomezskoWhitehead Institute for Biomedical Research, Cambridge, MA, USA; Program in Virology, Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.
Harish SwaminathanWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Silvi RouskinWhitehead Institute for Biomedical Research, Cambridge, MA, USA. Electronic address: srouskin@wi.mit.edu.
Whitehead Institute for Biomedical Research · USBrigham and Women's Hospital · US

Funding

HIV-1 RNA structure effects on latency reversalR21AI134365 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI ROUSKIN, SILVIA · 2017 to 2018
$571k
NIAID NIH HHS R21 AI134365
6 · The paper itself

Abstract

RNA structure is critically important to RNA viruses in every part of the replication cycle. RNA structure is also utilized by DNA viruses in order to regulate gene expression and interact with host factors. Advances in next-generation sequencing have greatly enhanced the utility of chemical probing in order to analyze RNA structure. This review will cover some recent viral RNA structural studies using chemical probing and next-generation sequencing as well as the advantages of dimethyl sulfate (DMS)-mutational profiling and sequencing (MaPseq). DMS-MaPseq is a robust assay that can easily modify RNA in vitro, in cell and in virion. A detailed protocol for whole-genome DMS-MaPseq from cells transfected with HIV-1 and the structure of TAR as determined by DMS-MaPseq is presented. DMS-MaPseq has the ability to answer a variety of integral questions about viral RNA, including how they change in different environments and when interacting with different host factors.

Indexed as

Genome, ViralHigh-Throughput Nucleotide SequencingMutagensMutationNucleic Acid ConformationReverse Transcriptase Polymerase Chain ReactionRNA, ViralRNA VirusesSequence Analysis, RNASulfuric Acid Estersdimethyl sulfateMutagensRNA, ViralSulfuric Acid EstersChemical probingDimethyl sulfateDMS-MaPseqNext-generation sequencingRNA structure

Identifiers

PMID32251733
PMCPMC7541462
OpenAlexW3014620365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.